FDA slams small phar­ma for mis­lead­ing ad with a dearth of safe­ty in­fo and du­bi­ous stat cal­cu­la­tions

The FDA’s Of­fice of Pre­scrip­tion Drug Pro­mo­tion slapped its 3rd un­ti­tled let­ter of the year on­to New Jer­sey-based Al­thera Phar­ma­ceu­ti­cals ear­li­er this month, with the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER